These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15544550)

  • 41. Salmosan, a β-galactomannan-rich product, in combination with Lactobacillus plantarum contributes to restore intestinal epithelial barrier function by modulation of cytokine production.
    Brufau MT; Campo-Sabariz J; Carné S; Ferrer R; Martín-Venegas R
    J Nutr Biochem; 2017 Mar; 41():20-24. PubMed ID: 27951516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions between the microbiota and the intestinal mucosa.
    Schiffrin EJ; Blum S
    Eur J Clin Nutr; 2002 Aug; 56 Suppl 3():S60-4. PubMed ID: 12142966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life.
    Bakker-Zierikzee AM; Alles MS; Knol J; Kok FJ; Tolboom JJ; Bindels JG
    Br J Nutr; 2005 Nov; 94(5):783-90. PubMed ID: 16277782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence.
    Frei R; Akdis M; O'Mahony L
    Curr Opin Gastroenterol; 2015 Mar; 31(2):153-8. PubMed ID: 25594887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The current concepts of the influence of lactobacilli on the immune system of the human body].
    Kostiuk OP; Chernyshova LI; Volokha AP
    Fiziol Zh (1994); 1997; 43(3-4):106-15. PubMed ID: 9303793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of intestinal barrier properties by probiotics: role in reversing colitis.
    Resta-Lenert SC; Barrett KE
    Ann N Y Acad Sci; 2009 May; 1165():175-82. PubMed ID: 19538304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prebiotics and probiotics in ulcerative colitis: where do we stand?
    Rogler G
    Digestion; 2011; 84(2):126-7. PubMed ID: 21494044
    [No Abstract]   [Full Text] [Related]  

  • 48. [Probiotics--an alternative for antibiotics?].
    Trafalska E; Grzybowska K
    Wiad Lek; 2004; 57(9-10):491-8. PubMed ID: 15765768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dietary fibres as "prebiotics": implications for colorectal cancer.
    Lim CC; Ferguson LR; Tannock GW
    Mol Nutr Food Res; 2005 Jun; 49(6):609-19. PubMed ID: 15864790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects.
    Marteau P; Shanahan F
    Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):725-40. PubMed ID: 14507584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Physiology of microflora in the digestive tract].
    Zboril V
    Vnitr Lek; 2002 Jan; 48(1):17-21. PubMed ID: 11852581
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maternal short-chain fructo-oligosaccharide supplementation increases intestinal cytokine secretion, goblet cell number, butyrate concentration and Lawsonia intracellularis humoral vaccine response in weaned pigs.
    Le Bourgot C; Le Normand L; Formal M; Respondek F; Blat S; Apper E; Ferret-Bernard S; Le Huërou-Luron I
    Br J Nutr; 2017 Jan; 117(1):83-92. PubMed ID: 28115029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn's disease.
    Steed H; Macfarlane GT; Blackett KL; Bahrami B; Reynolds N; Walsh SV; Cummings JH; Macfarlane S
    Aliment Pharmacol Ther; 2010 Oct; 32(7):872-83. PubMed ID: 20735782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intestinal microbiota; relevance to obesity and modulation by prebiotics and probiotics.
    da Silva ST; dos Santos CA; Bressan J
    Nutr Hosp; 2013; 28(4):1039-48. PubMed ID: 23889619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Probiotics restore the intestinal microflora. Modern life style has eradicated also the "good" bacteria].
    Cedgård L; Widell A
    Lakartidningen; 2001 Dec; 98(50):5753-5. PubMed ID: 11789097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design of a randomised controlled trial on immune effects of acidic and neutral oligosaccharides in the nutrition of preterm infants: carrot study.
    Westerbeek EA; van Elburg RM; van den Berg A; van den Berg J; Twisk JW; Fetter WP; Lafeber HN
    BMC Pediatr; 2008 Oct; 8():46. PubMed ID: 18947426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How can we impact the immune system with pre- and probiotics?
    Schiffrin EJ; Donnet A; Blum S
    Nestle Nutr Workshop Ser Clin Perform Programme; 2005; 10():203-217. PubMed ID: 15818031
    [No Abstract]   [Full Text] [Related]  

  • 58. Probiotics, prebiotics and colorectal cancer prevention.
    Ambalam P; Raman M; Purama RK; Doble M
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prebiotics and probiotics: are they functional foods?
    Roberfroid MB
    Am J Clin Nutr; 2000 Jun; 71(6 Suppl):1682S-7S; discussion 1688S-90S. PubMed ID: 10837317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microbiome dynamic modulation through functional diets based on pre- and probiotics (mannan-oligosaccharides and Saccharomyces cerevisiae) in juvenile rainbow trout (Oncorhynchus mykiss).
    Gonçalves AT; Gallardo-Escárate C
    J Appl Microbiol; 2017 May; 122(5):1333-1347. PubMed ID: 28256031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.